Euro-Med Laboratories Phil., Inc. (PSE:EURO)

PSE:EURO Revenue

Euro-Med Laboratories Phil. had revenue of 1.70B PHP in the quarter ending June 30, 2026, with 5.17% growth. This brings the company's total for the last twelve months to 6.92B, up 5.92% year-over-year. In the year 2025, Euro-Med Laboratories Phil. had annual revenue of 6.87B with 18.50% growth. That makes Euro-Med Laboratories Phil. the 21,998th largest company in the world by revenue and 115th in the Philippines.

• Revenue (ttm): 6.92B
• Revenue Growth: +5.92%
• P/S Ratio: 0.68
• Revenue / Employee: 3.82M
• Employees: 1,811
• Market Cap: 4.69B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing Pharmaceutical Products 5.07B 72.2%
• Providing Health and Other Care Services 990.92M 14.1%
• Development and Operation of Quick Service Restaurant 964.66M 13.7%

By Geography

Chart

• Philippines 6.71B 97.7%
• ASEAN 86.08M 1.3%
• Others 68.05M 1.0%
• Other Asian countries 4.31M 0.1%

Fiscal year ended Dec 31, 2025 See the full PSE:EURO breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.87B	1.07B	18.50%
Dec 31, 2024	5.80B	532.11M	10.11%
Dec 31, 2023	5.26B	1.04B	24.62%
Dec 31, 2022	4.22B	636.71M	17.75%
Dec 31, 2021	3.59B	-241.73M	-6.31%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error